Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity

Area of Science:

• Immunology
• Endocrinology
• Cardiovascular Disease

Background:

• Aldosterone excess causes hypertension and cardiovascular disease via inflammation.
• Dendritic cells (DCs) control T cell responses, making their modulation by aldosterone a key area of study.

Purpose of the Study:

• To investigate if aldosterone modulates dendritic cell (DC) function.
• To determine the impact of aldosterone-mediated DC modulation on T cell activation and autoimmune responses.

Main Methods:

• Assessed aldosterone's effect on CD8(+) T cell activation in a DC-dependent manner.
• Investigated mineralocorticoid receptor expression and signaling pathways (MAPK, IL-6, TGF-beta) in DCs.
• Evaluated the impact of aldosterone-stimulated DCs on CD4(+) T cell differentiation (Th17 phenotype).
• Utilized experimental autoimmune encephalomyelitis (EAE) model to assess aldosterone's role in autoimmune disease progression.

Main Results:

• Aldosterone augmented CD8(+) T cell activation via DCs.
• DCs expressed mineralocorticoid receptors and responded to aldosterone with MAPK activation and cytokine secretion (IL-6, TGF-beta).
• Aldosterone-promoted DCs induced a Th17 phenotype in CD4(+) T cells.
• Aldosterone exacerbated EAE, an autoimmune disease mediated by Th17 cells.
• Mineralocorticoid receptor blockade inhibited aldosterone's effects on DCs and attenuated EAE.

Conclusions:

• Aldosterone modulates DC function, enhancing CD8(+) T cell activation.
• Aldosterone promotes Th17-polarized immune responses through DC modulation.
• These aldosterone-induced immune changes may contribute to inflammatory damage in hypertension and cardiovascular disease.